Xiaole H. Su

382, WuYi Road
Taiyuan, 030001, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Potential targets and molecular mechanisms of D-pinitol against acute kidney injury based on network pharmacology and experimental validation.

Potential targets and molecular mechanisms of D-pinitol against acute kidney injury based on network pharmacology and experimental validation.

Journal: Renal failure
Published: August 11, 2026

Development and Validation of a Nomogram for Predicting Acute Kidney Injury in Acute Respiratory Distress Syndrome.

Development and Validation of a Nomogram for Predicting Acute Kidney Injury in Acute Respiratory Distress Syndrome.

Journal: Journal of inflammation research
Published: May 07, 2026

Intermedin prevents acute heart failure following acute kidney injury by alleviating inflammatory responses.

Intermedin prevents acute heart failure following acute kidney injury by alleviating inflammatory responses.

Journal: Renal failure
Published: January 12, 2026

Response to the Letter to the Editor Entitled "Reconsideration of Response Assessment in Obinutuzumab-Treated Membranous Nephropathy".

Response to the Letter to the Editor Entitled "Reconsideration of Response Assessment in Obinutuzumab-Treated Membranous Nephropathy".

Journal: Kidney international reports
Published: January 02, 2026

Retrospective analysis of serum NELL-1 and EXT1/2: no significant predictive value for treatment response in a cohort of membranous nephropathy patients.

Retrospective analysis of serum NELL-1 and EXT1/2: no significant predictive value for treatment response in a cohort of membranous nephropathy patients.

Journal: Renal failure
Published: October 06, 2025

Enteric-coated Mycophenolate Sodium plus hydroxychloroquine therApy versus hydroxychloroquine for the Remission of Proteinuria in IgA Nephropathy (EMSAR-IgAN trial): study protocol for a randomised trial.

Enteric-coated Mycophenolate Sodium plus hydroxychloroquine therApy versus hydroxychloroquine for the Remission of Proteinuria in IgA Nephropathy (EMSAR-IgAN trial): study protocol for a randomised trial.

Journal: BMJ open
Published: April 27, 2025

Intermedin protects peritubular capillaries by inhibiting eNOS uncoupling through AMPK/GTPCH-I/BH4 pathway and alleviate CKD following AKI.

Intermedin protects peritubular capillaries by inhibiting eNOS uncoupling through AMPK/GTPCH-I/BH4 pathway and alleviate CKD following AKI.

Journal: Free radical biology & medicine
Published: March 10, 2025

Nomogram risk prediction model for acute respiratory distress syndrome following acute kidney injury.

Nomogram risk prediction model for acute respiratory distress syndrome following acute kidney injury.

Journal: Frontiers in medicine
Published: January 20, 2025

Immune Imbalance in Primary Membranous Nephropathy at Single-cell Resolution.

Immune Imbalance in Primary Membranous Nephropathy at Single-cell Resolution.

Journal: Frontiers in bioscience (Landmark edition)
Published: December 13, 2024

Roles of microRNAs in cardiorenal syndrome.

Roles of microRNAs in cardiorenal syndrome.

Journal: Molecular and cellular biochemistry
Published: September 07, 2024

Risk factors and early prediction of cardiorenal syndrome type 3 among acute kidney injury patients: a cohort study.

Risk factors and early prediction of cardiorenal syndrome type 3 among acute kidney injury patients: a cohort study.

Journal: Renal failure
Published: May 09, 2024

Enteric-coated Mycophenolate Sodium therApy versus cyclophosphamide for induction of Remission in Microscopic PolyAngiitis (EMSAR-MPA trial): study protocol for a randomised controlled trial.

Enteric-coated Mycophenolate Sodium therApy versus cyclophosphamide for induction of Remission in Microscopic PolyAngiitis (EMSAR-MPA trial): study protocol for a randomised controlled trial.

Journal: BMJ open
Published: March 12, 2024
Showing 1-12 of 37

Last Updated: 09/26/2026